Ventaira Pharmaceuticals, Inc.

Ventaira Pharmaceuticals, Inc.

Ventaira Pharmaceuticals, Inc.

Overview
Date Founded

1999

Headquarters

1801 Watermark Drive,Suite 100,Columbus, OH 43215-1037

Type of Company

Private

Industries

Pharmaceuticals

Company Description

Ventaira Pharmaceuticals Inc. develops aerosol devices. It offers inhaled drugs, including fentanyl for the treatment of breakthrough pain and salmeterol/flucticasone for asthma. The company was founded in April 2000 and is headquartered in Columbus, OH.

Executives & Employees

Chief Scientist & Vice President-Pharmaceutical Development

Senior Vice President-Regulatory & Clinical Affairs

Board of Directors

General Partner at Cardinal Partners

President & Chief Executive Officer at Aevi Genomic Medicine, Inc.

Director-Horne Engineering at Franklin University

Paths to Ventaira Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Ventaira Pharmaceuticals, Inc.
Recent Transactions
Details Hidden

Battelle Memorial Institute purchases Ventaira Pharmaceuticals, Inc.

Investors
Details Hidden

TL Ventures is an active manager which provides financing in early- stage capital requirements, as well as providing management support. The firm targets young companies operating in software, information technology, and business sectors that are located in the US. The firm looks to take minority stake positions in its investments.

Details Hidden

James Richardson & Sons Ltd. engages in international grain trade and agri-food business, energy, real estate, financial services and investments. It offers agriculture and food processing, energy exploration, development and marketing, financial services, and real estate services. The company was founded by James Richardson in 1857 and is headquartered in Winnipeg, Canada.

Details Hidden

Novitas Capital seeks investment opportunities in companies located in the Mid-Atlantic region with a primary focus on Pennsylvania (. The firm target companies operating in the sectors: technology and life science. They provide financing for seed and early stage capital requirements with an initial investment size ranging between $0.25 and $2.0 million and invest up to $8.0 million over the lifetime of a portfolio investment.Novitas Capital acts as a lead investor also participates in board seat. They also makes follow on investment.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ventaira Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ventaira Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Ventaira Pharmaceuticals, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/ventaira-pharmaceuticals-inc-123426
  • https://relationshipscience.com/organization/ventaira-pharmaceuticals-inc-123426